As­traZeneca is leav­ing the lob­by­ing group PhRMA, third drug­mak­er to ditch trade group in last five months

As­traZeneca has joined Te­va and Ab­b­Vie in de­part­ing the US drug lob­by group Phar­ma­ceu­ti­cal Re­search and Man­u­fac­tur­ers of Amer­i­ca, say­ing it made the de­ci­sion to end its mem­ber­ship af­ter eval­u­at­ing the re­la­tion­ship.

The British drug­mak­er is the third ma­jor phar­ma to leave the group in the past five months.

“We reg­u­lar­ly eval­u­ate our mem­ber­ships with in­dus­try trade as­so­ci­a­tions,” an As­traZeneca spokesper­son said in an emailed state­ment. “Giv­en the sig­nif­i­cant in­vest­ment, we want to en­sure it is the most pro­duc­tive and ef­fec­tive use of our re­sources.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

Cambridge, MA, USA